Feb 12 (Reuters) - Novo Holdings, the controlling shareholder of Danish drugmaker Novo Nordisk, plans to invest up to $7 billion annually by 2030, the Financial Times reported on Monday. (Reporting by Mrinmay Dey in Bengaluru; Editing by Janane Venkatraman)